Literature DB >> 25972955

Cystic pilomyxoid astrocytoma on suprasellar region in 7-year-old girl: Treatment and strategy.

Mardjono Tjahjadi1, M Zafrullah Arifin1, Mirna Sobana1, Astri Avianti1, M Sinatrya Caropeboka1, Priandana Adya Eka1, Hasrayati Agustina2.   

Abstract

Pilomyxoid astrocytoma (PMA) is a recently described entity with similar features to pilocytic astrocytoma but with a rare occurrence. As a new diagnosis, no treatment guideline of PMA has been established; but generally, as for any low-grade gliomas, radical resection is performed if the location is favorable. In this report, we wished to share our experience treating the PMA. The authors presented a case of a 7-year-old girl with bitemporal hemianopia. From the history, the patient had a 4-month history of headache, following with nausea and projectile vomiting 1 week before hospital admission. Past history of seizure, weakness of left extremities, and decreased consciousness were reported. Computed tomography (CT) scanning showed acute obstructive hydrocephalus and an isohypodense mass at suprasellar region with the cystic component. We performed ventriculo-peritoneal-shunt to reduce the acute hydrocephalus, followed by craniotomy tumor removal 2 weeks later. The patient underwent radiotherapy and medical rehabilitation. Diagnosis of PMA was made on the basis of pathologic anatomy result, which showed a myxoid background with pseudorosette. Postoperative CT showed a residual tumor at right parasellar area without hydrocephalus. After the surgery, the treatment was followed with radiotherapy for 20 times within 2 months. Postradiation CT performed 1-year later showed a significant reduction of the tumor mass. There were no new postoperative deficits. The patient had improvement of the visual field and motor strength. The authors reported a case of a 7-year-old girl with PMA. Surgical resection combined with radiotherapy was performed to control the growth of PMA. More observation and further studies are required to refine the treatment methods.

Entities:  

Keywords:  Pediatric brain tumor; pilomyxoid astrocytoma; suprasellar tumor

Year:  2015        PMID: 25972955      PMCID: PMC4421961          DOI: 10.4103/1793-5482.154989

Source DB:  PubMed          Journal:  Asian J Neurosurg


Introduction

Pilomyxoid astrocytoma (PMA) is a type of tumor resembling pilocytic astrocytoma (PA), yet differs in a clinical course and histopathological findings. As a new diagnosis, there were no treatment guidelines for PMA established. We reported a case of cystic PMA on suprasellar region in a 7-year-old girl at our institution.

Case Report

Chief complaint

A 7-year-old girl was presented in the authors’ department with decreased consciousness.

Medical history and examination

The patient had a headache since 4 months prior to admission, which has gotten worse since 6 weeks before being hospitalized. She also vomited 1–2 times/day. Visual field disturbance was also noted. One day before admission, she complained of severe headache and projectile vomiting. Physical examination revealed decreased consciousness with the Glasgow coma scale score of 12 (E3M5V4) accompanied by weakness on left extremities with motor strength score of 4. Other physical examinations were found within normal limit.

Imaging

Head computed tomography (CT) scan of this patient showed an isohypodense mass at suprasellar region with solid and cystic configuration, ventricular systems were enlarged with the periventricular edema suggesting acute hydrocephalus. Nonhomogenous contrast enhancement was found particularly at suprasellar region [Figure 1].
Figure 1

(a and b) Noncontrast preoperative head computed tomography (CT) scan showed isohypodense mass at suprasellar region that extends into parasellar region and third ventricle; an acute obstructive hydrocephalus was shown. (c and d) Postcontrast preoperative head CT scan showed inhomogen enhancement of the mass at suprasellar region (c) Mass size was measured 5 cm × 5 cm × 4 cm

(a and b) Noncontrast preoperative head computed tomography (CT) scan showed isohypodense mass at suprasellar region that extends into parasellar region and third ventricle; an acute obstructive hydrocephalus was shown. (c and d) Postcontrast preoperative head CT scan showed inhomogen enhancement of the mass at suprasellar region (c) Mass size was measured 5 cm × 5 cm × 4 cm

Operative treatment

The authors performed an emergency ventriculo-peritoneal (VP)-shunt to reduce intracranial pressure (ICP) caused by hydrocephalus. Shortly after the procedure, patient's general condition improved. Craniotomy tumor removal was performed 2 weeks afterward using pterional transsylvian approach. The tumor was firm and reddish in color, it wrapped the internal carotid artery (ICA), the proximal part of middle cerebral artery, anterior cerebral artery, and its branches. Optic apparatus and pituitary stalk were also wrapped by the tumor [Figure 2a]. An intratumoral cyst was found containing a yellowish liquid. Tumor had extended into the third ventricle and attached in the wall of the third ventricle. The tumor was partially removed about 80%; parts that strongly attached to the ICA, pituitary stalk and hypothalamus were left behind [Figure 2b]. Postoperative CT showed reduction of the tumor mass with visible remnant especially at right parasellar area [Figure 3a and b]. Radiotherapy was eventually proposed to control the residual tumor.
Figure 2

(a) Intraoperative finding: A reddish gray tumor mass with firm consistency was encountered at suprasellar region. Tumor mass encased optic apparatus, internal carotid artery with its branches and pituitary stalk. (b) After subtotal tumor removal: Majority of neurovascular structures were released from the tumor encasement. Tumor mass attached to the hypothalamus, pituitary stalk, and ICA branches was left behind. AC = Anterior cerebral artery; ICA = Internal carotid artery; MCA = Middle cerebral artery; OC = Optic chiasm; ON = Optic nerve; Tu = Tumor mass; TR = Tumor remnant

Figure 3

(a and b) Postoperative computed tomography (CT) scan showed a reduction of the tumor mass especially at the suprasellar region. (c and d) 1-year postradiotherapy CT scan, the enhancement of tumor remnant as shown on (a) (yellow arrowhead) was significantly reduced after radiotherapy (c), yellow arrow head]. Ventricle system was enlarged, but the shunt pump was still effective, and the patient did not complain any intracranial hypertension sign

(a) Intraoperative finding: A reddish gray tumor mass with firm consistency was encountered at suprasellar region. Tumor mass encased optic apparatus, internal carotid artery with its branches and pituitary stalk. (b) After subtotal tumor removal: Majority of neurovascular structures were released from the tumor encasement. Tumor mass attached to the hypothalamus, pituitary stalk, and ICA branches was left behind. AC = Anterior cerebral artery; ICA = Internal carotid artery; MCA = Middle cerebral artery; OC = Optic chiasm; ON = Optic nerve; Tu = Tumor mass; TR = Tumor remnant (a and b) Postoperative computed tomography (CT) scan showed a reduction of the tumor mass especially at the suprasellar region. (c and d) 1-year postradiotherapy CT scan, the enhancement of tumor remnant as shown on (a) (yellow arrowhead) was significantly reduced after radiotherapy (c), yellow arrow head]. Ventricle system was enlarged, but the shunt pump was still effective, and the patient did not complain any intracranial hypertension sign

Adjuvant treatment

In the postoperative course, some neurological deficits included weakness on the extremities, headache, and visual problems were improved. Within 3 weeks after surgery, the patient was directly sent to the radiotherapy department to receive linear accelerator (LINAC) electra shot at 180 cGy for 20 times within 2 months. The mass measurement for radiation was constructed in three-dimensional and the area of radiation was extended to 2 mm of the tumor border. If the surrounding area is vital, we only radiate the tumor within the border. During radiation therapy, there was no major complaint, except minimal nausea. Concerning the child's growth, the patient was followed-up in the neurosurgery outpatient clinic, altogether with neuropediatrician, ophthalmologist and physiatrist. Further improvement on motor strength, visual acuity, and visual field were reported. Only slight astigmatism was found on both eyes. One-year postradiotherapy CT showed a significant reduction of the mass size [Figure 3c and d].

Histopathological evaluation

The tumor cells are dominated markedly by mucoid matrix and composed of monomorphic bipolar cells with angiocentric cells arrangement [Figure 4a–c]. This finding was consistent with the diagnosis of PMA. Cerebrospinal fluid (CSF) analysis did not reveal any malignant cells.
Figure 4

(a) Histopathological result revealed pseudorosette formation (H and E, magnification × 200). (b) Monomorphous population of tumor cells in a myxoid matrix (H and E, magnification ×100). (c) Angiocentric arrangement of tumor cells (H and E, magnification × 200)

(a) Histopathological result revealed pseudorosette formation (H and E, magnification × 200). (b) Monomorphous population of tumor cells in a myxoid matrix (H and E, magnification ×100). (c) Angiocentric arrangement of tumor cells (H and E, magnification × 200)

Discussion

Pilomyxoid astrocytoma was proposed in 1999 by Tihan et al. as a separate diagnosis from PA because of its histological configurations which determine patient's prognosis.[1] As a recently described astrocytic neoplasm entity, this lesion has not been included in the current (2000) World Health Organization classification.[234] Characteristically, PMA is more aggressive with higher rate of local recurrence and leptomeningeal dissemination.[2] PMA usually found in infant and very young children (3 months to 2 years), with mean presentation about 10–18 months.[24567] Some reports mentioned about PMA in older patients.[89] The survival rates of PMA are worse than PA; with progression-free-survival about 26 months and overall survival of 63 months.[24] The predilection of PMA is in the neuraxis, especially in the hypothalamus or optic chiasm.[2610] Seldom, this tumor was found in the cerebellum and cervical spinal cord.[461112] Histologically, PMA shows marked myxoid matrix with small, compact, piloid, and highly monomorphic cells. Perivascular rosettes were often found. Different from PA, this tumor shows no Rosenthal fibers and rare eosinophilic granular bodies.[11213] As with the majority of pediatric brain tumors, PMA most commonly presents with symptoms of increased ICP or parenchymal compression, including failure to thrive, developmental delay, altered level of consciousness, vomiting, feeding difficulties, and generalized weakness.[791114] Several studies revealed patients with decreased visual field and acuity while others reported the presence of diencephalic syndromes.[5611] In cases of spinal cord PMA, the presenting symptoms are neck pain and weakness of extremities.[1214] Until this time, there were no definitive pathognomonic imaging findings to distinguish PMA from PA.[2810] On head CT, PAs typically shows heterogeneous enhancement with a substantial cystic component, while PMAs typically enhance homogeneously and demonstrate solid composition; those facts could help in differentiating PMA from PA.[4] Hemorrhage due to spontaneous intratumoral bleeding was reported in PMA but not in PA; however it also requires further investigation.[10] In several studies, magnetic resonance imaging was used as a gold standard to differentiate PMA from PA but still did not reveal any specific difference. One study has suggested the usage of magnetic resonance spectroscopy to distinguish PMA from PA, although further studies were needed.[410] The management for PMA is still controversial and was greatly influenced by tumor location.[14] Gross total resection of newly diagnosed tumors, provided it can be performed without unacceptable sequelae, is the most powerful predictor of a favorable outcome in children. For the patient with hydrocephalus, CSF diversion by external drainage or VP-shunt could be performed.[911] As for residual tumors, the role of adjuvant therapy is still questionable.[1234] Chemotherapy as an adjuvant therapy for PMA has been mentioned in several reports. For the time being, chemotherapy is usually applied judiciously for inoperable or partially resected tumors and may delay the need for radiotherapy in early childhood. Radiotherapy is generally reserved for patients older than 5 years old after an initial surgical resection and have tumors located near the midline.[210] In the authors’ case, the treatment course was begun by performing CSF diversion by VP-shunt in order to manage the hydrocephalus followed by craniotomy tumor removal as the patient's general condition improved. Postoperative radiotherapy was performed, as the patient is considered old enough to accept the radiation dose. The patient's condition improved after the authors’ course of treatment. Twenty-six months after radiotherapy, no clinical deterioration was reported, and the patient could perform her daily activities well.

Conclusion

The authors reported a case of a 7-year-old girl with PMA. Surgical resection combined with radiotherapy was performed to control the growth of PMA. More observation and further studies are required to refine the treatment methods.
  14 in total

1.  Pilomyxoid astrocytoma of the cervical spinal cord successfully treated with chemotherapy: case report.

Authors:  Kazuhito Matsuzaki; Teruyoshi Kageji; Hiroyoshi Watanabe; Takanori Hirose; Shinji Nagahiro
Journal:  Neurol Med Chir (Tokyo)       Date:  2010       Impact factor: 1.742

2.  Juvenile pilomyxoid astrocytoma in the opticohypothalamus.

Authors:  Sung-Hyun Kim; Sam-Suk Kang; Tae-Young Jung; Shin Jung
Journal:  J Korean Neurosurg Soc       Date:  2010-11-30

3.  Pediatric cerebellar pilomyxoid-spectrum astrocytomas.

Authors:  Jonathan A Forbes; Bret C Mobley; Thomas M O'Lynnger; Calvin M Cooper; Mahan Ghiassi; Rimal Hanif; Matthew M Pearson
Journal:  J Neurosurg Pediatr       Date:  2011-07       Impact factor: 2.375

4.  Successful treatment of leptomeningeal gliomatosis of pilomyxoid astrocytoma after failed frontline chemotherapy.

Authors:  Mizuhiko Terasaki; Eric Bouffet; Mitsuhide Maeda; Yasuo Sugita; Yutaka Sawamura; Motohiro Morioka
Journal:  Neurologist       Date:  2012-01       Impact factor: 1.398

Review 5.  Pilomyxoid astrocytoma: a review.

Authors:  Ricardo J Komotar; J Mocco; Benjamin S Carson; Michael E Sughrue; Brad E Zacharia; Alexander C Sisti; Peter D Canoll; Alexander G Khandji; Tarik Tihan; Peter C Burger; Jeffery N Bruce
Journal:  MedGenMed       Date:  2004-12-09

6.  Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors.

Authors:  Michael W Johnson; Charles G Eberhart; Arie Perry; Tarik Tihan; Kenneth J Cohen; Marc K Rosenblum; Soroush Rais-Bahrami; Patricia Goldthwaite; Peter C Burger
Journal:  Am J Surg Pathol       Date:  2010-12       Impact factor: 6.394

7.  Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome.

Authors:  T Tihan; P G Fisher; J L Kepner; C Godfraind; R D McComb; P T Goldthwaite; P C Burger
Journal:  J Neuropathol Exp Neurol       Date:  1999-10       Impact factor: 3.685

8.  Pilomyxoid astrocytoma of the cerebellum.

Authors:  Olufemi A Ajani; Ghanem Al Sulaiti; Issam Al Bozom
Journal:  J Neurosurg Pediatr       Date:  2011-05       Impact factor: 2.375

9.  MR imaging characteristics of pilomyxoid astrocytomas.

Authors:  Atilla Arslanoglu; Bayram Cirak; Alena Horska; James Okoh; Tarik Tihan; Leslie Aronson; Anthony M Avellino; Peter C Burger; David M Yousem
Journal:  AJNR Am J Neuroradiol       Date:  2003-10       Impact factor: 3.825

10.  Pilomyxoid astrocytoma: expanding the imaging spectrum.

Authors:  L L Linscott; A G Osborn; S Blaser; M Castillo; R H Hewlett; N Wieselthaler; S S Chin; J Krakenes; G L Hedlund; C L Sutton
Journal:  AJNR Am J Neuroradiol       Date:  2008-08-13       Impact factor: 3.825

View more
  2 in total

1.  Posterior fossa pilomyxoid astrocytoma with spontaneous hemorrhage in pediatric patients.

Authors:  Jintao He; Xiang Li; Wanchun Zhu; Chunde Li; Jian Gong
Journal:  Childs Nerv Syst       Date:  2017-07-24       Impact factor: 1.475

Review 2.  Nanomedicine in Clinical Photodynamic Therapy for the Treatment of Brain Tumors.

Authors:  Hyung Shik Kim; Dong Yun Lee
Journal:  Biomedicines       Date:  2022-01-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.